What was the tussle over Covaxin IPR? | Explained
Image for representation. | Photo Credit: The Hindu The story so far: The maker of the indigenous coronavirus vaccine, Covaxin, Bharat Biotech International Limited (BBIL), has admitted to an “inadvertent error” in patent filings to protect the vaccine’s Intellectual Property Rights (IPR). One of India’s leading biotechnology companies, it had failed to include scientists from…
Read More “What was the tussle over Covaxin IPR? | Explained” »
